rfhg_23997.1

Basic information about the TSS

---

TSS ID: rfhg_23997.1 TSS ID(Version3): hg_27308.1 hg_27310.1 hg_27309.1 hg_27307.1 Species: human Chr: chr2		Start: 24076284 End: 24076484 Strand: -
Source datasets	FANTOM5|PRJNA615891|PRJNA401781|PRJNA4843412|DRA013844 |PRJNA597322|PRJNA548673|PRJDB5282
Protocol	CAGE|TIF-seq2|SLIC_CAGE|RAMPAGE|oligo_capping|NETCAGE |STRIPE-seq|ReCappable-seq|C1CAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3098969,EH38E1980335)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000233468.5:0 ENST00000478050.1:0 AF151868:0 BC015463:0 AK311118:0 AK000621:0 AF184213:0 AF161523:0 AK311908:0 DQ581903:0 GeneID: 51639 HGNC/MGI_ID: HGNC:30096 UniProt_ID: Q9Y3B4 Nearer transcript ids and distances: JF432474:55 KJ893958:55 AB527769:55 AF401310:55 view more...

Gene_name: splicing factor 3b subunit 6 Gene_symbol: SF3B6 Gene_synonyms: CGI-110 Ht006 P14 SAP14a SF3B14a Gene_source: HGNC:30096

TATA-Box annotation

---

Distance to TSS:	-58
Nearest PromoterID:	NM_016047
Entrez ID:	51639
Nearest Unigene:	Hs.177861
Nearest Refseq:	NM_016047
Nearest Ensembl:	ENSG00000115128
Gene Name:	splicing factor 3b subunit 6
Gene Alias:	CGI-110|HSPC175|Ht006|P14|SAP14|SAP14a|SF3B14|SF3B14a
Gene Type:	protein-coding
CpG%:	0.105000
GC%:	0.597015
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SF3B6 p2@SF3B6 p3@SF3B6 p4@SF3B6 p5@SF3B6 p6@SF3B6 p7@SF3B6
Sample		p1@SF3B6	p2@SF3B6	p3@SF3B6	p4@SF3B6	p5@SF3B6	p6@SF3B6	p7@SF3B6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	183.50	7.01	5.06	10.91	4.48	0.97	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	187.14	6.47	7.28	9.91	5.87	1.62	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	207.76	11.57	3.28	9.84	5.02	1.35	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	176.31	10.60	5.61	10.19	5.61	0.42	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	182.00	9.00	6.52	11.47	2.92	1.80	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	216.10	10.85	8.33	11.24	4.46	1.36	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	326.83	10.24	12.20	13.07	6.75	2.61	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	233.98	8.96	7.75	11.87	3.88	1.70	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	212.22	7.27	8.12	10.47	4.70	2.78	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	122.30	12.17	6.38	16.23	4.06	0.58	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	95.00	8.49	6.87	10.51	4.85	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	110.99	10.57	4.88	8.54	3.66	2.03	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	124.76	4.19	3.71	2.42	0.64	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	133.66	3.76	2.41	2.56	0.30	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	157.64	4.83	3.95	4.17	0.22	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	120.97	5.28	2.51	2.01	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	147.86	3.28	3.06	4.37	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	127.39	2.95	3.37	2.53	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	144.48	4.80	1.07	2.13	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	145.93	5.12	4.06	2.41	0.30	0.75	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	142.34	3.61	2.81	3.74	0.40	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	164.68	5.70	6.39	4.32	0.17	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	145.67	4.78	4.14	1.94	0.39	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	146.57	4.85	3.64	4.13	1.21	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	153.50	4.64	3.35	2.32	0.52	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	180.73	3.17	5.06	4.75	0.32	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	172.53	4.95	3.85	2.75	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	162.43	4.48	5.66	3.54	0.24	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	151.83	3.88	3.07	3.72	1.13	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	153.64	3.62	4.34	3.44	0.54	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	166.85	4.19	4.19	5.23	0.63	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	153.37	5.08	3.71	4.49	0.59	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	172.83	3.17	2.32	3.80	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	296.89	6.43	9.57	7.59	0.66	1.48	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	167.73	4.11	4.86	3.93	0.93	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	135.09	3.26	3.07	3.45	0.00	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	150.83	4.50	4.50	3.88	0.61	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	158.77	2.42	5.84	2.42	0.00	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	204.47	3.78	8.10	5.67	0.27	1.35	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	178.61	4.80	6.00	5.04	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	145.63	3.06	3.76	1.88	0.47	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	198.95	2.93	7.03	6.73	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	157.54	4.01	3.80	4.22	0.00	1.48	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	154.55	4.37	3.67	3.32	0.87	0.70	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	188.53	4.42	6.63	5.02	0.40	2.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	198.21	6.05	4.65	5.58	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	142.74	5.04	3.60	3.36	0.72	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	196.41	5.07	6.56	7.15	0.30	1.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	135.01	2.63	2.39	2.15	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	146.59	4.04	6.07	4.45	0.40	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	136.91	4.51	5.12	2.66	0.41	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	146.54	5.34	4.00	2.45	0.44	1.56	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	783.56	13.99	55.97	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	118.17	3.90	3.90	2.84	0.71	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	114.00	4.97	2.65	1.66	0.33	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	921.99	12.58	25.17	24.33	4.19	5.87	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	298.05	10.56	7.81	11.48	1.38	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	95.94	4.54	1.62	1.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	90.57	3.53	3.21	2.57	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	226.63	10.06	5.97	5.97	1.57	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	87.43	4.94	2.82	0.71	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	80.19	3.36	2.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	285.82	6.37	8.76	5.57	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	146.78	5.78	5.10	2.04	0.68	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	70.51	3.25	1.95	1.62	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	79.16	4.26	1.77	1.77	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	565.74	16.16	48.49	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	710.77	15.79	15.79	0.00	23.69	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	106.77	4.39	3.41	1.95	0.49	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	121.98	3.47	2.48	0.99	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	105.55	2.35	2.81	1.41	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	138.11	1.99	2.32	1.32	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	126.83	2.17	2.17	1.86	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	96.31	2.45	1.53	0.61	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	138.43	2.53	2.69	2.06	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	94.65	2.57	0.96	0.80	0.48	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	144.78	2.16	1.78	1.91	0.38	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	113.62	2.24	2.99	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	136.65	1.00	2.01	1.67	0.67	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	168.43	1.28	4.47	2.55	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	69.27	1.10	0.00	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	161.23	1.35	1.35	1.35	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	78.72	1.91	0.70	0.35	0.70	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	146.48	4.89	1.56	1.96	0.39	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	99.35	4.63	1.80	1.29	0.26	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	98.69	6.13	1.12	1.12	0.56	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	94.64	5.88	1.76	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	126.36	5.63	0.97	1.77	0.24	0.16	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	115.22	4.20	1.29	1.29	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	93.84	2.67	0.00	1.07	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	100.72	2.23	0.00	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	109.80	4.57	0.83	2.08	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	107.25	4.52	0.00	0.75	0.00	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	79.85	1.64	0.98	0.65	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	62.72	1.52	0.30	0.61	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	213.48	7.07	3.54	2.65	1.99	1.10	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	105.78	3.94	1.43	2.51	1.43	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	67.09	5.99	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	120.18	9.36	2.88	2.16	0.90	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	92.04	8.37	5.02	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	98.82	9.66	1.03	1.44	0.41	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	236.40	12.01	3.09	2.75	0.46	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	144.74	4.41	2.20	0.73	0.24	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	176.57	2.70	4.94	2.25	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	171.49	3.91	1.74	2.60	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	171.22	6.42	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	153.65	5.98	2.09	2.09	0.60	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	223.84	2.53	2.53	1.26	0.00	1.26	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	124.75	6.60	3.96	2.64	1.32	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	149.77	5.52	1.30	1.95	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	167.48	3.88	3.40	4.37	0.00	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	152.03	6.53	2.97	2.97	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	179.66	3.77	1.51	2.64	0.38	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	157.47	1.45	1.45	0.00	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	126.63	6.27	3.76	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	199.00	4.78	3.46	2.97	0.33	0.66	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	185.61	5.46	5.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	172.20	5.13	2.71	2.41	0.15	0.30	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	149.48	4.82	1.07	2.68	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	152.47	1.51	2.65	3.40	0.57	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	159.30	3.21	3.21	2.67	0.00	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	161.93	1.95	1.95	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	157.90	2.49	1.66	1.66	0.33	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	153.69	7.20	1.20	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	212.41	0.00	0.00	3.54	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	148.37	3.09	2.06	1.89	0.86	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	163.60	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	185.43	0.49	3.88	1.94	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	199.59	4.55	4.55	4.17	0.00	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	150.21	2.42	0.00	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	164.17	2.85	3.42	2.85	1.14	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	144.94	5.13	2.14	1.28	0.21	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	135.76	3.61	2.32	2.06	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	162.81	4.69	2.35	2.35	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	139.55	2.25	0.96	1.61	0.96	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	141.26	6.42	0.71	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	167.88	1.75	4.09	1.17	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	154.75	4.52	1.81	3.61	0.60	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	154.44	13.07	3.56	3.56	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	201.90	6.61	4.07	4.07	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	190.76	5.35	1.78	1.78	1.27	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	125.80	4.45	3.18	1.27	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	157.08	3.02	6.04	0.86	0.43	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	169.98	3.18	2.12	2.54	0.00	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	142.38	4.35	1.45	3.48	0.58	0.00	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	171.94	0.94	1.89	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	150.03	3.22	2.03	2.03	0.34	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	143.61	4.63	4.63	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	211.26	4.23	4.23	8.45	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	146.44	3.65	0.86	1.50	0.86	0.64	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	161.85	4.21	3.61	3.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	201.93	2.19	3.64	2.92	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	179.31	5.98	2.53	3.22	1.15	1.15	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	132.62	0.00	5.10	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	234.40	7.37	3.31	4.58	0.76	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	164.95	4.13	2.27	2.68	0.41	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	144.13	3.37	2.45	2.45	0.31	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	191.20	4.30	2.87	3.35	0.48	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	161.87	2.66	1.55	2.22	1.11	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	146.48	0.00	3.05	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	189.43	3.32	2.22	5.54	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	163.38	3.18	1.85	2.91	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	140.29	2.54	2.91	2.54	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	243.18	6.26	3.32	2.95	0.86	0.61	1.11
Astrocyte - cerebellum, donor2	11580-120F5	129.40	1.88	1.20	0.17	0.34	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	126.06	4.82	2.73	2.10	1.05	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	230.76	12.55	6.27	2.44	0.00	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	187.50	7.12	3.40	3.88	0.49	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	183.62	8.95	2.09	1.64	0.15	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	255.98	12.62	1.26	3.10	0.80	0.00	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	286.02	12.90	2.76	3.01	0.25	0.25	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	269.13	12.06	1.82	2.05	0.46	0.23	0.34
Basophils, donor1	12241-129G9	111.94	8.63	2.09	1.31	0.00	0.78	0.00
Basophils, donor2	12242-129H1	175.71	8.66	2.16	2.53	0.36	1.08	0.00
Basophils, donor3	12243-129H2	91.43	7.06	0.59	0.88	0.15	0.00	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	144.89	9.92	1.51	1.94	0.43	1.08	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	38.40	1.37	0.00	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	215.21	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	214.03	3.14	1.26	5.02	0.63	2.51	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	34.94	1.04	0.42	0.21	0.21	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	80.60	2.99	1.84	1.15	0.92	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	207.30	10.98	1.44	2.34	1.26	1.08	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	256.61	12.78	0.62	1.96	0.93	0.21	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	435.30	7.69	8.15	6.99	0.93	1.63	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	318.82	22.70	6.08	9.59	0.00	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	506.76	31.03	10.34	41.37	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	81.15	6.76	0.56	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	69.23	5.57	0.74	1.48	0.00	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	69.15	7.24	0.66	0.66	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	112.93	5.94	0.28	0.00	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	109.93	5.69	0.00	0.00	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	123.28	6.57	0.00	0.33	0.66	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	86.01	6.36	1.16	1.88	0.00	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	59.44	5.13	0.91	0.30	0.60	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	80.31	5.69	0.71	0.71	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	60.60	6.03	1.00	0.50	0.17	0.17	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	46.09	6.07	0.83	0.00	0.28	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.25	10.41	0.25	0.50	0.25	0.25	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	48.36	15.47	0.59	0.59	0.20	0.20	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	58.58	9.44	0.53	1.07	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	102.07	19.37	0.65	1.31	0.22	0.44	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	52.21	12.41	0.94	0.23	0.70	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	60.72	10.03	1.58	0.53	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	76.55	6.66	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	60.84	8.03	0.74	0.45	0.00	0.30	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	58.87	6.19	1.00	1.80	0.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	127.83	13.74	1.25	2.91	0.42	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	56.05	14.41	0.92	0.92	0.46	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	67.64	6.11	1.81	1.13	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	57.18	5.67	0.44	0.87	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	64.56	7.53	0.81	0.27	0.27	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	66.64	6.80	1.74	0.70	0.00	0.00	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	80.80	10.52	0.00	1.68	0.00	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	44.83	13.04	0.55	0.92	0.00	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	43.68	10.92	0.00	0.35	1.06	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	48.70	15.36	1.32	1.32	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	48.82	10.46	0.17	0.52	0.35	0.00	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	47.95	7.81	0.37	1.12	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	107.99	15.09	0.86	1.94	0.00	0.00	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	51.19	11.88	0.00	0.41	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	62.35	9.97	1.39	1.62	0.23	0.70	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	83.52	18.79	0.93	1.62	0.23	0.46	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	174.15	5.23	0.87	0.65	0.65	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	179.94	3.46	0.92	0.92	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	199.72	7.58	0.22	0.43	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	191.23	8.10	0.93	1.09	0.00	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	169.40	10.30	0.87	0.87	0.17	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	174.14	9.14	0.45	0.67	0.22	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	231.95	7.40	1.28	1.28	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	164.23	5.93	0.66	0.66	0.44	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	198.12	5.68	0.84	0.42	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	323.14	20.32	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	252.21	18.98	0.00	0.68	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	253.72	20.71	0.00	0.00	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	278.25	19.72	0.53	1.60	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	250.88	25.73	0.54	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	250.59	21.76	0.70	0.70	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	276.09	22.75	0.78	0.00	0.00	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	313.75	29.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	111.78	6.58	0.82	4.11	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	124.77	10.16	3.63	2.90	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	113.08	8.08	3.53	2.52	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	517.60	33.94	5.25	5.66	4.44	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	441.84	23.97	3.60	3.20	1.20	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	259.04	17.07	5.02	6.02	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	269.67	14.61	13.48	15.17	1.12	2.81	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	274.68	13.53	5.64	6.76	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	362.13	21.42	8.79	9.02	0.23	0.90	1.13
CD4+ T Cells, donor1	11225-116C1	172.10	17.14	2.86	3.21	0.00	1.79	0.36
CD4+ T Cells, donor2	11306-117C1	180.65	12.86	3.67	3.67	0.00	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	143.35	10.98	1.83	2.74	0.30	1.22	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	234.82	3.57	1.28	0.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	214.49	9.21	0.00	0.00	0.22	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	214.45	2.87	0.57	0.57	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	314.32	15.65	1.90	3.79	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	338.52	14.75	0.00	2.81	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	227.44	3.30	0.00	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	202.61	6.79	2.02	1.30	0.00	0.00	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	158.28	8.81	1.19	1.53	0.34	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	143.96	6.29	0.81	1.13	0.48	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	257.32	17.93	2.24	2.69	0.00	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	261.69	13.63	1.40	3.49	0.35	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	246.83	9.24	1.32	1.76	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	231.48	5.90	1.69	1.69	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	158.74	4.99	0.21	0.83	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	167.73	4.01	1.67	0.33	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	193.89	13.32	1.90	0.54	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	227.78	7.50	0.00	0.54	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	161.39	14.35	0.00	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	211.20	7.60	1.30	1.85	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	178.49	6.93	1.30	0.22	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	186.40	8.20	0.84	1.47	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	286.17	17.70	1.01	4.55	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	282.91	9.10	3.47	4.77	0.43	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	265.85	13.51	2.18	3.92	0.00	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	292.47	21.28	1.48	1.48	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	262.18	10.16	0.00	0.92	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	336.39	23.73	1.40	1.40	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	322.34	8.58	0.55	0.83	0.28	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	354.84	11.29	0.74	0.49	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	263.34	13.86	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	273.96	16.83	1.79	0.36	0.00	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	303.31	15.23	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	191.20	8.51	3.93	2.95	0.00	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	150.55	9.39	3.00	5.26	0.00	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	167.40	8.58	0.76	2.02	0.00	1.26	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	175.71	3.44	16.06	18.58	1.15	4.13	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	163.20	6.23	16.54	17.73	1.44	2.88	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	218.60	6.57	20.25	20.52	1.37	2.46	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	278.60	4.50	25.82	33.32	1.50	3.90	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	168.71	3.12	14.40	21.36	2.16	2.88	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	176.68	5.00	17.05	17.28	1.14	4.09	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	236.19	5.87	13.91	19.99	1.52	2.17	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	212.67	5.53	10.79	17.63	2.37	2.11	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	230.76	5.86	14.31	13.84	2.11	2.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	277.73	4.23	25.36	25.96	3.32	2.42	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	237.34	4.36	18.01	23.24	1.74	2.32	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	229.13	3.20	21.85	21.58	1.87	4.80	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	109.00	1.31	9.63	10.07	0.00	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	125.24	1.37	10.93	14.12	0.00	1.82	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	91.00	1.49	5.97	8.95	0.75	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	182.96	3.96	17.65	18.01	1.80	4.68	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	170.91	4.03	14.39	17.84	1.15	2.30	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	164.28	3.54	16.73	14.61	1.65	1.41	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	253.52	5.39	18.06	19.65	1.27	5.07	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	204.22	7.07	13.84	17.22	1.85	3.69	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	210.62	5.45	11.22	13.46	2.56	2.89	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	224.89	4.59	19.51	24.86	1.91	4.21	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	204.93	6.31	13.40	25.22	0.79	5.12	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	204.23	2.27	18.15	27.23	0.76	4.54	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	180.67	5.62	32.92	30.51	4.82	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	195.84	6.99	32.87	30.77	7.69	3.50	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	178.31	3.01	22.04	30.05	3.01	8.01	0.00
Cardiac Myocyte, donor1	11525-119I4	91.39	1.83	1.83	5.48	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	186.27	4.94	1.98	1.48	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	179.84	4.21	2.00	1.37	0.32	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	197.95	4.16	2.77	2.77	0.00	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	80.67	3.55	1.42	1.07	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	119.81	2.84	1.82	2.73	0.11	0.23	0.11
Chondrocyte - re diff, donor2	11339-117F7	138.76	4.48	0.90	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	129.00	4.04	1.62	0.81	0.40	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	253.27	11.71	2.41	2.30	0.23	0.46	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	189.40	8.98	5.77	2.78	0.43	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	181.07	7.88	3.63	1.42	0.00	0.18	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	119.85	5.04	1.65	1.01	1.10	0.18	1.10
Corneal Epithelial Cells, donor1	11526-119I5	99.25	4.83	0.88	1.10	0.22	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	121.72	1.14	1.14	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	145.97	4.35	2.30	1.53	1.53	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	152.22	5.28	1.16	1.82	0.33	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	153.60	6.94	2.52	1.89	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	234.65	3.45	10.35	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	101.83	4.64	0.54	1.51	0.00	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	156.81	10.59	1.71	1.71	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	280.73	16.97	2.61	1.96	0.00	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	298.59	3.87	4.84	3.39	0.00	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	87.55	4.17	1.00	1.17	0.17	0.33	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	79.21	2.93	0.00	1.17	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	104.07	4.52	2.55	1.13	0.00	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	64.48	1.97	1.18	0.79	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	78.54	1.75	0.58	1.45	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	92.70	3.29	3.29	1.41	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	125.00	3.68	1.58	2.10	0.18	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	139.20	6.65	1.33	1.77	0.00	0.22	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	123.23	5.48	2.13	1.52	0.00	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	127.70	4.51	0.85	1.13	0.00	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	172.04	5.05	1.49	2.97	0.30	1.49	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	114.03	1.56	1.04	1.56	0.52	1.56	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	72.31	5.39	0.85	0.71	0.28	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	289.29	5.20	2.80	4.80	0.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	83.34	2.10	1.57	1.05	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	256.07	9.94	3.73	3.73	0.62	0.87	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	129.05	3.26	1.30	1.52	0.43	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	138.74	5.74	1.95	1.83	0.12	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	59.15	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	55.18	1.40	0.70	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	120.74	2.98	2.04	2.83	0.16	0.31	0.31
Eosinophils, donor1	12244-129H3	106.73	45.74	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	278.89	128.72	0.00	1.65	0.00	0.00	3.30
Eosinophils, donor3	12246-129H5	199.74	82.04	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	118.99	5.38	1.95	0.00	0.98	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	79.05	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	260.30	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	131.36	2.87	3.69	2.87	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	124.27	3.18	3.50	1.64	0.33	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	193.27	3.25	3.25	2.28	0.98	0.65	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	203.14	3.88	4.73	3.76	0.24	1.09	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	106.04	1.50	0.82	1.09	0.27	0.41	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	125.09	2.64	2.11	2.00	0.32	0.32	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	85.37	1.05	1.58	0.53	0.26	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	148.83	3.99	1.99	1.00	0.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	136.09	3.18	3.18	3.18	0.91	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	44.72	1.52	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	87.37	2.37	1.26	1.58	0.32	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	159.43	3.94	2.73	0.91	0.30	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	161.68	1.90	2.92	1.90	0.38	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	185.10	4.09	2.43	0.76	0.45	0.76	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	161.46	3.08	1.61	1.07	0.40	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	132.45	2.59	4.75	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	249.01	4.39	4.39	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	160.76	5.07	3.69	2.54	1.61	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	185.72	7.12	2.04	2.04	0.00	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	211.07	2.82	1.41	0.94	0.94	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	134.90	2.83	1.89	0.94	1.42	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	210.70	5.08	3.51	1.69	0.24	0.48	0.24
Fibroblast - Dermal, donor4	11450-119A1	200.88	4.07	1.70	0.90	1.13	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	247.03	2.79	4.19	2.44	0.87	0.87	0.87
Fibroblast - Dermal, donor6	11458-119A9	253.87	6.33	2.27	1.79	1.30	0.49	0.49
Fibroblast - Gingival, donor1	11237-116D4	181.58	4.37	2.29	0.83	0.83	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	171.09	2.88	3.41	3.67	0.00	0.00	0.79
Fibroblast - Gingival, donor2	11318-117D4	209.54	8.70	1.98	1.58	1.05	0.00	0.66
Fibroblast - Gingival, donor3	11394-118C8	124.44	3.09	1.26	0.39	0.39	0.00	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	114.28	2.08	2.08	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	90.22	3.17	1.94	0.70	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	191.13	7.17	3.27	3.59	0.31	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	180.39	4.06	2.30	2.30	0.95	0.41	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.06	0.35	0.00	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	181.93	4.83	2.78	3.07	0.00	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	212.17	6.54	2.59	2.32	0.41	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	186.37	4.61	2.74	2.74	0.66	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	131.18	3.37	2.49	1.76	0.29	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	46.22	6.80	0.00	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	210.39	7.46	2.98	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	133.16	6.12	0.84	0.84	0.21	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	235.75	5.00	2.50	0.00	1.67	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	100.70	2.80	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	74.45	1.96	1.68	0.84	0.00	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	207.45	5.68	3.25	0.81	0.00	0.81	1.22
Fibroblast - Mammary, donor2	11620-122A9	107.84	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	172.73	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	268.07	10.47	3.30	0.19	0.19	0.58	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	184.90	7.74	1.52	0.91	0.46	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	156.97	3.98	0.92	1.22	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	130.13	1.91	2.29	1.91	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	160.37	3.24	3.24	3.24	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	75.04	1.97	1.04	1.28	0.35	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	239.19	5.97	3.76	3.43	0.44	0.66	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	143.45	5.28	1.22	1.42	0.61	0.00	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	122.95	5.35	0.67	2.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	170.40	5.54	3.95	1.58	1.58	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	100.22	1.79	0.79	1.19	0.60	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	191.29	4.80	3.37	1.42	0.18	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	211.67	6.11	2.76	2.37	0.79	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	102.89	4.51	1.20	0.90	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	248.83	3.56	3.78	3.13	0.65	0.65	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	108.82	1.01	1.27	1.01	0.76	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	176.88	4.43	2.30	1.64	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	93.24	1.80	1.60	1.60	0.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	239.60	3.11	3.62	3.21	0.90	0.60	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	127.54	0.91	1.81	1.21	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	197.92	5.38	2.73	1.74	0.17	0.25	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	260.53	2.05	3.93	3.59	0.00	0.17	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	84.41	1.31	1.31	0.99	0.00	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	208.25	3.94	2.88	2.02	0.21	0.32	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	204.27	5.23	3.37	3.20	0.17	0.51	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	364.14	6.12	10.04	6.12	0.31	0.94	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2614.86	22.16	22.16	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	158.62	10.46	1.74	1.74	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	149.26	7.45	3.47	1.73	0.17	0.69	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	193.62	8.33	2.34	4.16	1.04	1.82	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	144.62	5.88	2.30	2.56	0.26	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	175.31	15.31	10.72	5.36	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	272.46	14.04	15.31	4.47	0.00	7.02	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	420.48	40.51	15.12	5.99	1.71	4.28	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	279.34	8.27	4.96	2.48	1.65	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	170.79	10.05	2.28	2.74	0.46	0.46	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	289.27	29.52	7.53	4.16	1.19	0.99	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	274.12	9.25	2.38	3.97	0.53	0.00	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	168.94	8.15	3.26	3.26	0.00	0.33	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	415.25	45.55	24.32	9.29	0.44	2.21	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	258.76	17.24	8.48	4.66	1.27	1.41	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	219.56	13.18	6.03	2.96	1.35	0.74	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	195.56	12.36	9.13	5.10	2.15	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	197.24	11.52	2.85	2.11	0.50	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	203.07	15.78	3.46	2.21	1.25	0.42	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	197.00	13.42	5.69	3.66	1.22	1.42	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	178.89	12.09	2.05	1.14	0.46	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	158.20	18.19	1.99	1.49	0.62	0.12	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	126.56	19.89	1.09	0.44	1.31	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	210.97	12.71	2.07	1.18	0.89	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	206.49	12.08	2.38	1.75	0.64	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	172.93	13.85	0.67	1.34	0.67	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	162.31	9.68	2.02	2.22	0.40	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	222.40	11.37	3.22	2.88	0.68	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	220.44	13.48	3.10	2.39	0.27	0.18	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	207.49	8.12	1.98	2.39	0.31	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	228.16	6.83	1.54	1.54	0.51	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	194.20	9.41	2.32	2.77	0.33	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	211.98	12.06	3.08	2.25	0.33	0.17	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	211.33	8.98	3.27	2.45	1.23	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	196.20	8.05	1.24	1.03	0.83	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	173.52	6.80	1.96	0.81	0.58	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	172.10	6.34	2.33	0.67	0.33	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	152.98	8.60	1.98	1.98	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	221.75	7.50	1.84	2.34	0.49	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	161.44	5.35	2.92	2.27	0.32	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	195.32	10.26	1.28	0.96	1.28	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	162.79	8.15	1.42	1.90	0.66	0.09	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	160.07	4.11	1.42	0.95	0.63	0.32	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	200.09	6.99	4.26	2.74	0.30	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	154.51	6.27	1.99	0.84	0.63	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	146.88	7.68	2.42	1.10	1.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	158.51	9.26	2.52	1.68	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	131.84	6.67	3.15	1.76	0.28	0.19	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	182.64	5.08	4.55	2.41	0.53	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	146.43	6.89	2.14	2.45	0.15	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	165.29	8.03	3.37	1.81	0.52	0.26	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	156.41	5.15	1.90	2.17	0.81	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	164.63	6.27	1.66	3.13	0.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	153.30	5.26	2.63	0.44	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	102.15	3.97	0.99	2.98	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	145.50	5.54	2.90	1.19	0.40	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	134.17	5.25	0.81	0.81	0.20	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	78.54	0.25	1.52	1.02	0.25	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	341.19	19.11	12.54	8.36	0.80	2.79	1.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	253.76	11.56	9.40	5.70	0.92	1.08	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	306.67	21.28	17.80	6.75	1.23	1.43	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	388.03	21.91	14.08	8.76	0.63	2.50	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	365.06	22.32	12.43	7.35	0.57	1.70	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	249.05	6.46	9.69	5.07	0.46	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	304.40	9.90	12.37	2.47	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	323.76	12.38	13.54	8.12	0.39	3.09	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	391.49	17.65	9.63	8.02	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	246.91	10.43	5.22	3.48	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	288.70	12.04	7.81	4.23	0.33	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	324.50	14.82	9.06	6.59	0.82	1.24	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	259.92	6.66	6.66	6.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	301.18	13.42	6.71	5.59	0.56	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	274.22	13.07	7.84	7.19	0.33	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	254.17	6.71	5.03	1.68	1.68	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	319.34	14.95	6.36	3.82	1.27	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	306.04	15.96	5.43	4.76	1.70	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	553.36	14.62	8.35	2.09	0.00	2.09	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	339.04	13.17	5.15	0.00	1.15	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	209.85	9.47	2.66	0.59	0.00	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	367.63	27.11	5.08	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	367.82	14.08	11.18	8.70	2.07	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	289.73	15.88	4.37	5.29	2.30	0.23	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	368.79	15.81	5.27	10.54	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	298.30	12.69	5.38	6.54	1.15	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	314.56	13.36	10.11	5.54	0.65	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	417.36	23.41	7.36	7.36	2.01	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	359.07	17.34	1.93	3.08	0.00	0.39	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	288.25	15.75	6.50	7.87	0.68	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	323.02	24.85	2.48	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	359.08	16.51	2.36	2.83	0.47	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	319.85	12.67	4.83	3.62	2.41	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	368.79	19.33	3.56	2.54	0.00	1.53	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	339.81	11.57	1.99	2.79	1.60	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	355.71	18.75	2.47	3.95	0.99	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	402.53	25.97	2.36	0.00	2.36	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	379.82	13.42	2.33	1.75	1.17	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	359.44	24.14	2.19	1.76	1.32	0.44	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	298.39	11.87	4.24	1.70	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	250.11	6.57	4.18	3.58	0.00	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	279.99	7.76	7.76	2.91	0.97	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	76.47	1.14	0.00	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	79.42	2.49	0.83	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	92.21	9.00	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	136.06	5.71	1.90	1.27	0.63	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	124.90	3.76	1.25	1.67	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	222.92	9.28	3.02	4.06	0.93	0.35	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	198.68	5.74	2.53	3.21	1.35	0.17	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	213.17	4.32	2.96	2.28	2.28	0.23	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	234.80	6.34	1.86	3.28	0.77	0.11	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	197.07	7.52	1.93	2.58	1.72	0.00	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	201.93	5.60	2.37	3.66	1.08	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	232.51	8.47	4.11	1.87	1.25	0.12	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	208.26	7.21	3.09	1.72	2.06	0.34	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	210.16	4.16	2.24	4.49	1.60	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	134.87	1.68	1.12	1.68	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	144.99	3.03	0.87	0.87	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	171.85	5.29	5.29	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	154.49	3.17	2.47	2.12	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	104.62	1.45	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	186.38	3.67	5.77	3.85	0.52	0.52	0.17
Hepatocyte, donor1	11523-119I2	113.80	9.68	0.00	1.21	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	121.74	17.24	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	92.03	4.29	0.61	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	231.05	1.96	1.31	4.57	1.96	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	255.88	45.44	3.15	1.92	1.05	0.87	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	229.68	7.00	2.74	2.33	0.27	0.82	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	56.76	0.00	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	62.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	73.13	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	92.59	12.99	1.62	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	58.36	1.67	1.67	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	76.24	3.63	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	55.59	2.65	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	80.93	5.54	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	111.49	3.78	0.00	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	80.42	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	92.38	3.88	1.94	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	45.08	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	11.95	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	84.75	5.70	1.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	42.82	2.10	0.42	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	81.98	5.63	2.41	0.80	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	65.55	2.77	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	107.62	1.89	1.89	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	78.91	0.91	0.91	1.81	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	92.55	1.08	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	69.88	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	61.85	0.64	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	56.50	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	54.27	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	125.01	4.01	2.47	0.93	1.23	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	59.70	5.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	78.58	3.14	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	55.63	1.39	0.00	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	2.21	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	87.53	3.24	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.08	4.36	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	58.49	4.50	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	3.48	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	48.00	3.20	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	62.34	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	46.02	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	81.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	53.93	2.11	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	108.61	3.10	2.69	2.28	0.82	1.14	0.16
Keratinocyte - epidermal, donor2	11349-117G8	53.88	0.00	0.00	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	267.50	4.92	5.58	3.79	0.85	1.61	0.38
Keratinocyte - oral, donor1	11251-116E9	400.72	12.37	7.04	3.18	1.59	2.04	0.34
Keratocytes, donor1	11527-119I6	225.21	5.50	4.47	1.38	0.34	0.69	1.03
Keratocytes, donor2	11607-120I5	132.41	3.52	2.34	2.34	2.34	1.17	1.17
Keratocytes, donor3	11688-122I5	195.03	6.13	1.78	2.57	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	131.87	2.20	2.20	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	171.52	2.16	3.24	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	211.17	14.42	1.38	1.04	0.35	0.23	0.69
Lens Epithelial Cells, donor3	11690-122I7	211.81	4.54	3.63	4.44	0.50	0.71	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	166.60	8.06	2.49	2.25	0.12	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	126.70	5.58	1.95	0.84	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	164.02	6.30	3.46	2.05	0.47	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	132.28	6.99	1.61	1.08	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	95.50	5.67	1.58	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	117.30	6.25	1.94	0.54	0.22	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	129.68	2.46	2.05	2.87	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	75.85	4.30	1.01	0.51	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	104.44	3.80	2.25	1.41	0.14	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	152.28	7.12	3.16	1.58	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	148.71	6.20	2.33	1.16	0.58	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	62.02	4.26	1.30	0.74	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	144.94	3.83	2.09	1.39	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	122.84	5.72	2.15	2.39	0.24	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	101.64	5.77	1.37	1.37	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	143.20	8.01	1.85	2.16	0.62	0.31	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	92.90	3.43	0.94	1.87	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	89.48	6.22	1.10	0.73	0.37	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	134.94	7.57	3.62	2.63	0.33	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	97.23	5.27	2.64	1.17	0.29	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	65.72	4.48	1.24	0.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	140.64	3.88	3.39	5.82	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	155.38	7.00	4.04	4.04	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	129.43	4.84	2.27	2.12	0.00	0.45	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	152.41	4.67	1.56	2.07	0.00	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	161.02	7.12	2.72	1.26	0.42	0.00	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	101.35	4.66	1.50	1.05	0.15	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	147.89	6.88	3.44	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	140.74	7.71	1.32	0.94	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	75.28	4.56	0.95	0.95	0.11	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	138.10	5.33	2.42	2.42	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	113.46	8.27	2.65	1.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	84.49	4.58	1.36	0.87	0.12	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	173.26	4.07	2.96	4.81	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	146.52	4.69	2.22	3.46	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	78.78	4.95	0.96	0.96	0.14	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	142.49	6.75	1.93	2.25	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	158.25	11.56	2.13	2.13	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	150.74	6.16	3.92	2.66	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	144.36	6.04	1.78	1.07	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	108.59	6.79	1.94	1.94	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	50.57	3.11	0.78	0.47	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	142.88	9.67	0.72	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	117.28	5.55	1.31	0.98	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	64.98	3.30	1.41	0.94	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	143.43	8.04	3.22	1.86	0.25	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	84.52	4.35	1.02	1.54	0.00	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	90.70	4.77	1.19	0.30	0.00	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	133.69	33.99	2.27	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	87.45	11.51	0.00	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	115.05	11.88	0.00	0.74	2.23	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	104.94	15.23	0.85	1.27	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	97.06	11.96	2.81	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	88.73	18.68	0.93	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	92.23	14.94	0.52	2.06	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	88.02	8.33	1.19	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	112.64	23.07	2.04	1.81	0.23	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	148.32	17.74	2.62	3.49	0.58	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	176.02	15.76	3.60	1.35	1.80	0.90	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	114.49	20.59	1.63	2.03	0.54	0.41	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	90.89	13.87	3.08	3.59	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	129.50	13.76	3.18	0.35	0.00	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	142.59	15.99	1.33	4.66	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	120.22	18.85	2.04	1.53	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	154.21	18.94	2.40	2.13	1.60	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	168.73	21.92	3.59	3.02	1.32	0.19	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	123.33	22.09	1.84	0.61	1.84	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	115.79	16.31	2.45	0.00	2.45	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	163.05	20.41	2.29	2.29	0.83	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	170.12	19.06	3.64	1.96	1.68	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	112.31	12.36	0.00	2.06	0.00	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	137.60	17.13	3.48	3.19	0.87	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	160.82	15.84	2.09	2.69	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	135.55	14.94	2.77	6.09	0.55	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	111.70	18.38	2.12	3.18	1.77	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	131.65	17.70	2.95	2.58	1.48	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	93.25	20.72	3.45	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	113.21	14.20	3.07	0.77	0.77	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	121.15	15.85	1.13	3.40	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	118.97	18.05	0.82	1.64	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	98.51	17.17	2.26	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	103.41	17.24	0.00	1.44	0.00	0.72	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	131.46	17.18	0.00	2.99	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	87.70	13.38	1.49	3.34	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	121.90	15.51	3.02	3.02	1.72	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	119.03	8.56	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	109.95	12.99	0.33	1.33	1.33	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	101.36	14.48	1.21	0.00	1.21	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	70.39	12.80	0.71	2.13	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	107.58	12.37	1.03	1.37	0.34	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	104.67	11.27	1.07	1.61	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	83.50	16.83	1.35	1.35	1.35	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	107.42	18.15	0.74	1.11	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	163.97	25.58	1.16	2.33	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	75.10	6.35	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	94.84	13.20	1.60	3.20	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	101.76	16.72	2.91	0.00	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	99.65	14.56	0.00	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	103.59	17.26	1.97	0.99	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	90.33	16.94	2.82	0.00	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	102.58	11.56	1.01	1.51	1.01	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	92.83	18.93	3.15	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	87.78	30.98	6.88	3.44	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	102.87	20.49	1.34	2.67	0.89	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	110.27	18.38	1.56	1.56	1.56	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	87.09	13.85	0.66	2.64	1.32	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	92.37	17.12	1.56	1.04	0.52	1.04	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	113.77	13.56	0.88	0.88	2.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	103.99	10.62	0.56	2.24	1.12	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	90.09	19.43	1.32	0.44	0.00	0.44	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	100.29	17.74	3.47	1.93	0.00	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	101.78	17.22	1.52	2.53	0.51	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	102.85	17.30	2.40	2.88	0.48	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	110.92	19.08	3.58	1.99	1.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	100.26	14.58	3.65	1.22	0.61	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	119.66	13.83	1.38	2.08	2.08	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	102.22	20.52	1.14	1.90	0.38	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	92.44	19.62	2.07	2.07	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	99.16	9.67	1.21	1.21	0.00	0.60	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	109.96	15.21	2.54	2.85	0.63	0.00	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	107.68	15.46	1.07	1.07	1.07	0.00	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	125.85	12.64	1.15	3.45	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	110.05	22.11	3.09	2.57	1.54	0.00	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	102.57	19.10	2.83	1.41	1.41	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	115.20	11.35	2.27	1.70	0.00	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	94.44	18.31	2.08	1.25	1.25	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	103.36	14.88	0.78	2.35	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	106.47	9.60	0.84	0.84	0.84	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	88.28	14.40	2.79	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	88.31	8.70	2.01	0.67	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	94.63	11.23	1.60	2.14	0.53	0.00	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	113.55	18.59	1.62	1.62	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	100.95	14.68	1.84	0.92	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	111.14	13.34	0.89	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	109.41	20.52	3.42	1.71	1.71	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	98.93	21.47	0.77	1.53	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	121.47	12.04	1.09	1.09	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	98.44	14.25	1.78	2.23	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	89.68	21.58	1.56	1.30	0.78	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	126.65	15.25	1.99	1.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	114.32	20.79	2.08	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	103.25	2.96	0.00	0.00	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	84.23	4.59	0.37	0.18	0.18	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	80.88	4.85	0.26	0.79	0.26	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	256.48	7.97	10.62	6.37	3.19	2.12	0.53
Mallassez-derived cells, donor2	11929-125I3	248.14	7.76	5.39	4.75	1.90	2.85	1.43
Mallassez-derived cells, donor3	11930-125I4	331.76	8.90	8.62	5.98	1.53	4.17	0.83
Mammary Epithelial Cell, donor1	11273-116H4	267.94	15.84	21.02	10.76	2.59	2.29	1.00
Mammary Epithelial Cell, donor2	11350-117G9	255.67	5.50	14.77	7.24	1.16	3.47	0.58
Mammary Epithelial Cell, donor3	11422-118F9	71.09	3.24	1.00	1.00	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	250.84	8.14	1.36	4.07	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	178.32	4.87	1.73	1.84	0.11	0.22	0.22
Mast cell, donor2	11565-120D8	119.76	3.86	0.30	0.59	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	158.04	5.40	0.90	1.58	0.45	0.45	0.45
Mast cell, donor4	11567-120E1	100.35	5.32	0.18	0.35	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	256.16	5.10	1.11	1.66	0.00	0.11	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	248.65	2.92	2.92	5.25	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	213.50	3.79	0.92	1.49	0.11	0.00	0.34
Mast cell, expanded, donor8	11941-126A6	150.46	6.03	1.00	1.67	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	203.77	13.83	1.69	2.19	0.10	0.40	0.70
Melanocyte - dark, donor2	11582-120F7	181.69	7.61	1.38	2.77	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	181.83	0.94	2.61	1.81	0.43	0.51	0.22
Melanocyte - light, donor1	11274-116H5	35.03	1.41	0.00	0.24	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	32.08	0.68	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	41.63	1.73	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	183.78	3.12	2.60	1.87	0.31	0.10	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	156.26	3.23	2.42	0.81	0.27	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	164.46	2.68	2.95	1.87	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	227.53	3.97	1.36	0.74	0.62	0.50	0.87
Meningeal Cells, donor2	11573-120E7	201.59	4.84	3.52	3.52	0.88	0.44	0.00
Meningeal Cells, donor3	11654-122E7	267.90	7.01	3.50	3.26	0.57	0.33	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	276.32	5.13	5.99	2.85	0.57	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	172.79	3.32	3.22	1.71	0.30	0.50	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	57.82	1.31	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	91.57	0.00	1.31	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	180.84	3.59	2.87	2.15	0.00	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	118.38	5.93	1.48	3.39	0.85	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	165.37	2.51	2.01	3.02	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	187.67	4.83	2.20	0.44	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	178.99	3.65	2.19	0.73	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	132.79	6.34	1.64	1.02	0.61	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	281.45	5.12	2.77	2.35	0.28	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	97.76	2.97	1.12	1.12	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	211.44	1.84	2.63	2.76	0.26	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	106.83	2.37	2.37	2.97	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	51.38	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	153.06	2.56	2.56	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	295.61	7.09	2.48	3.54	0.35	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	190.76	2.19	1.25	1.25	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	250.36	2.18	1.45	2.90	2.18	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	148.23	3.18	1.86	0.53	0.00	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	146.14	6.51	1.00	2.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	87.95	3.04	0.87	1.16	0.22	0.36	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	86.69	4.43	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	74.50	2.94	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	82.76	4.96	0.62	0.31	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	71.98	3.11	0.41	0.62	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	88.34	3.25	0.25	0.25	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	64.70	1.86	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	79.86	3.25	0.41	0.41	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	57.81	4.75	0.00	0.00	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	69.03	3.54	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	93.84	2.66	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	74.49	4.46	0.64	0.21	0.21	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	0.92	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	41.13	3.28	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	84.05	6.27	0.50	0.25	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	52.29	3.57	0.24	0.24	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.61	2.21	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	69.76	7.60	0.46	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	47.33	4.42	0.42	1.05	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	43.01	5.71	0.20	0.41	0.00	0.00	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	77.45	4.29	0.43	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	47.13	2.89	0.00	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	43.80	6.35	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	34.47	2.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	35.33	4.35	0.82	0.54	0.00	0.00	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.41	2.65	0.59	0.29	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	54.30	6.73	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	61.64	6.40	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	48.06	6.51	0.50	0.50	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	67.88	10.07	0.44	0.44	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	74.13	8.43	0.50	1.49	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	2.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	70.43	4.79	0.34	1.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.01	1.75	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.04	1.42	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	75.19	5.33	1.40	0.84	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.02	2.08	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	0.58	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	43.74	1.51	0.30	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	50.92	4.59	0.42	1.25	0.83	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.02	1.85	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	39.27	2.28	0.00	1.14	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.93	2.49	0.83	0.28	0.14	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	68.42	5.44	0.78	0.26	0.00	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	38.61	1.72	0.00	0.43	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	1.27	0.00	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	37.36	2.40	0.27	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	70.34	4.49	0.60	1.20	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	34.47	1.84	0.57	0.42	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	82.18	6.37	0.64	0.96	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	58.60	4.20	0.66	1.11	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.24	1.14	1.14	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	79.27	5.11	0.85	0.00	0.28	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	93.65	3.20	0.25	0.49	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	15.64	1.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	61.75	4.12	0.88	0.59	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	77.56	2.02	0.86	0.00	0.58	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	50.28	3.30	1.65	2.06	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	53.60	2.68	0.30	0.89	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	146.91	15.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	106.94	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	119.27	2.63	0.66	0.99	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	94.68	5.26	0.00	1.05	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	108.33	8.70	0.59	0.40	0.20	0.00	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	77.30	4.66	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	103.27	4.51	0.00	0.75	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	80.44	6.66	0.00	0.00	0.53	0.27	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	122.94	6.11	0.57	0.68	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	57.46	2.95	0.74	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	87.94	3.66	0.73	0.37	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	94.89	3.11	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	247.98	11.22	0.53	1.60	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	56.56	3.03	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	106.25	2.53	0.42	0.84	1.26	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	168.88	8.17	0.00	1.36	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	78.20	4.45	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	145.77	4.05	0.00	3.24	1.62	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	187.29	6.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	34.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	159.86	26.10	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	19.01	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	191.74	2.59	2.80	2.80	0.43	0.65	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	182.39	4.70	5.23	3.14	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	68.08	3.34	0.00	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.80	1.67	0.42	0.42	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	151.73	8.94	2.66	1.52	0.76	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	103.73	3.19	3.19	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	34.00	2.04	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	496.16	9.19	7.35	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	53.15	2.09	1.26	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	83.91	4.18	1.63	0.93	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	41.61	1.62	0.54	0.27	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	80.10	5.05	0.63	1.26	0.42	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	534.47	0.00	0.00	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	65.02	4.47	0.99	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	107.46	6.23	2.17	0.27	0.81	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	62.56	2.04	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	36.91	1.47	0.49	0.16	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	104.98	2.73	1.09	1.46	0.36	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	61.53	0.53	0.53	1.06	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.61	1.80	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	197.89	4.59	3.61	2.95	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.19	0.98	0.16	0.81	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	91.72	2.29	1.23	1.23	0.18	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	52.74	0.70	0.00	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	48.73	1.38	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	76.48	3.86	1.29	0.32	0.64	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	226.59	7.59	4.14	2.41	0.34	1.03	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	384.32	17.70	10.11	7.59	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	77.53	2.67	1.11	0.89	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	48.27	1.69	1.27	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	51.03	2.61	1.42	0.47	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	79.41	2.15	0.86	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	659.03	0.00	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	37.65	1.67	0.33	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	55.01	0.45	1.80	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	73.41	2.38	1.19	0.40	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	62.22	1.86	0.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	102.54	1.51	0.76	1.14	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	45.62	2.28	0.00	0.98	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	27.89	0.87	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	72.82	2.26	0.90	0.90	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	49.39	1.76	1.76	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	60.50	2.66	0.00	1.33	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	65.97	0.99	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	44.02	1.15	0.77	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	105.86	2.12	0.60	0.91	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	97.47	2.87	0.66	0.88	0.66	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	59.63	1.36	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	541.61	0.00	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	85.97	1.22	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	37.77	0.63	0.00	0.31	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	32.69	0.61	0.00	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	91.77	1.58	1.58	0.79	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	216.53	2.27	1.13	1.13	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	697.99	0.00	10.12	15.17	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	160.75	4.97	1.49	3.35	0.75	0.12	0.50
Myoblast, donor2	11322-117D8	154.39	6.14	1.92	2.30	0.96	0.00	0.58
Myoblast, donor3	11398-118D3	153.03	7.40	1.85	1.35	0.50	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	236.56	12.70	2.77	1.46	0.58	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	186.36	7.69	3.38	3.38	0.31	2.15	0.00
Natural Killer Cells, donor2	11311-117C6	130.27	6.63	3.62	5.73	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	122.58	7.91	2.76	2.02	0.00	0.74	0.00
Neural stem cells, donor1	11275-116H6	258.78	11.25	6.53	6.17	1.45	1.09	0.73
Neural stem cells, donor2	11352-117H2	161.75	13.48	1.93	9.63	0.00	0.00	0.00
Neurons, donor1	11494-119E9	361.85	6.83	6.83	3.41	2.28	2.28	1.14
Neurons, donor2	11574-120E8	286.87	7.93	4.62	5.94	0.00	0.44	0.22
Neurons, donor3	11655-122E8	398.75	8.22	9.87	9.04	0.00	1.64	0.00
Neutrophils, donor1	11233-116C9	141.06	110.43	0.00	0.93	0.93	0.00	5.57
Neutrophils, donor2	11314-117C9	89.87	55.08	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	165.54	146.60	0.61	1.22	1.22	0.00	5.50
Nucleus Pulposus Cell, donor1	11252-116F1	221.32	11.16	2.85	1.54	0.47	0.24	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	159.22	6.19	0.98	2.93	0.00	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	185.11	2.81	3.61	1.80	0.20	0.60	0.80
Olfactory epithelial cells, donor1	11933-125I7	115.08	4.27	2.62	1.65	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	161.10	3.33	5.07	3.76	0.87	0.43	0.29
Olfactory epithelial cells, donor3	11935-125I9	121.68	2.84	1.82	2.04	0.34	0.45	0.11
Olfactory epithelial cells, donor4	11936-126A1	131.68	1.85	1.66	1.95	0.19	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	225.08	9.63	3.61	4.21	1.20	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	86.35	3.83	0.64	0.43	0.43	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	29.72	1.14	1.14	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	84.42	3.72	1.24	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	60.00	2.35	0.98	1.17	0.20	0.39	0.00
Osteoblast, donor2	11354-117H4	229.66	3.51	5.62	3.51	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	94.55	3.91	1.24	0.89	0.71	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	212.69	5.73	4.21	2.44	0.25	0.51	0.42
Pericytes, donor1	11491-119E6	152.99	3.00	0.89	0.89	0.67	0.11	0.22
Pericytes, donor2	11571-120E5	182.90	4.07	0.23	1.58	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	159.71	4.48	1.42	1.63	0.41	0.20	0.41
Perineurial Cells, donor1	11499-119F5	252.38	6.56	2.60	1.47	0.34	0.68	0.45
Perineurial Cells, donor2	11579-120F4	212.82	6.07	3.77	2.12	0.37	0.55	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	145.98	7.01	0.96	1.27	0.00	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	95.01	6.86	1.22	1.47	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	88.52	5.69	0.91	0.78	0.39	0.65	0.13
Placental Epithelial Cells, donor1	11278-116H9	196.36	59.55	2.87	1.43	0.48	0.00	2.63
Placental Epithelial Cells, donor2	11355-117H5	98.69	7.76	1.11	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	71.86	8.05	1.57	1.37	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	142.40	2.22	1.58	2.85	0.95	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	127.37	2.06	2.44	2.06	0.38	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	66.05	1.70	0.26	0.91	0.26	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	124.73	1.80	4.50	2.48	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	138.31	2.13	2.66	2.24	0.32	0.64	0.00
Preadipocyte - omental, donor2	11329-117E6	148.40	3.49	1.31	1.31	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	154.57	2.44	2.29	3.15	0.14	0.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	92.52	0.98	2.95	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	40.85	2.76	0.00	0.00	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	231.26	7.97	1.42	2.83	1.06	0.53	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	216.26	5.96	4.60	3.41	0.85	0.51	0.85
Preadipocyte - visceral, donor1	11280-116I2	254.29	5.78	4.10	2.98	0.93	0.47	0.37
Preadipocyte - visceral, donor2	11357-117H7	191.90	3.22	3.68	1.84	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	193.83	3.97	2.61	2.72	0.42	0.31	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	285.71	41.33	6.94	4.37	1.51	1.51	2.26
Prostate Epithelial Cells, donor2	11331-117E8	98.17	5.55	1.62	1.90	0.41	0.95	0.14
Prostate Epithelial Cells, donor3	11404-118D9	149.91	15.74	0.31	0.49	1.65	0.12	0.73
Prostate Stromal Cells, donor1	11254-116F3	215.84	6.04	3.99	4.33	0.80	0.68	0.34
Prostate Stromal Cells, donor2	11332-117E9	182.17	3.94	3.41	2.69	0.36	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	121.59	5.32	1.88	1.46	0.42	0.31	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	112.05	6.93	0.36	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	209.81	10.05	2.36	1.66	0.76	0.14	0.49
Renal Epithelial Cells, donor1	11517-119H5	75.58	3.55	0.00	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	122.35	6.40	0.71	1.42	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	251.11	7.52	1.69	2.96	0.53	0.53	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	105.53	4.09	0.68	0.00	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	160.23	3.10	1.48	1.62	0.27	0.54	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	181.83	6.22	2.89	2.89	0.89	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	72.53	1.33	2.00	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	143.72	5.94	1.32	1.54	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	148.60	11.91	1.88	0.63	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	74.62	2.50	1.66	1.11	0.55	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	159.44	11.27	1.61	0.54	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	102.47	5.90	0.84	0.00	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	116.29	7.91	0.96	0.96	0.39	0.00	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	235.69	9.59	2.85	0.00	1.04	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	165.15	7.67	2.56	1.14	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	136.87	3.09	3.09	0.00	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	283.53	11.79	8.03	4.27	0.25	1.76	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	135.11	10.82	0.53	0.80	0.13	0.00	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	423.47	16.08	16.97	26.80	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1454.63	41.83	50.63	84.21	6.60	8.26	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1232.62	39.44	34.80	63.23	5.22	5.22	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	483.95	7.15	15.60	17.81	0.78	1.56	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	329.79	8.84	14.40	12.61	0.79	0.79	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	523.34	12.05	23.53	18.63	0.89	1.90	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	653.21	10.67	24.93	20.10	1.49	1.74	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	402.55	9.09	17.48	16.90	1.05	0.82	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	496.70	12.94	23.34	17.80	2.54	0.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	373.21	7.12	12.18	17.52	0.55	1.10	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	351.26	8.93	14.67	13.01	1.06	0.61	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	429.34	12.90	15.95	16.84	0.72	0.54	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	407.56	7.03	14.92	13.63	1.58	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	378.61	7.51	13.20	12.77	1.72	0.32	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	425.94	9.51	18.59	16.82	1.77	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	362.47	5.74	14.34	14.15	1.34	1.34	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	308.74	8.11	10.34	12.67	1.30	0.84	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	548.13	13.53	21.42	19.35	0.75	1.32	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	315.05	7.56	10.88	10.35	1.46	0.80	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	326.09	8.86	15.57	10.90	0.88	1.56	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	424.12	9.74	18.71	17.57	0.95	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	372.82	5.98	12.82	13.46	1.07	1.28	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	341.69	7.57	14.58	11.77	1.12	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	352.05	8.20	12.30	11.79	1.54	0.85	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	349.71	5.11	12.76	14.04	1.28	0.55	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	322.65	9.81	16.80	13.24	1.23	1.10	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	395.84	11.15	17.60	14.91	1.61	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	530.48	8.73	17.22	25.24	2.59	1.89	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	353.77	4.56	14.29	13.49	1.19	0.40	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	428.17	8.42	18.24	13.80	1.17	3.04	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	421.14	9.75	15.14	16.38	2.49	0.62	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	428.26	8.63	21.90	17.03	1.33	0.88	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	320.43	10.24	14.20	11.28	1.25	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	421.52	8.61	14.27	14.94	1.08	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	275.88	6.13	10.22	10.90	1.53	1.02	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	337.78	9.64	15.62	12.53	1.74	0.96	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	434.83	8.60	11.69	17.88	1.03	0.34	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	272.14	7.96	11.93	8.92	0.82	0.27	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	400.24	11.49	17.07	14.94	2.30	1.15	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	350.06	5.45	13.98	10.91	1.19	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	343.56	9.62	10.65	10.95	0.89	1.18	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	260.95	8.53	10.40	11.73	1.07	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	330.73	6.64	12.03	12.17	1.52	1.11	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	315.96	6.19	8.10	10.95	1.19	1.19	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	301.91	6.45	11.29	14.31	1.81	1.01	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	295.80	4.71	8.57	10.64	0.66	0.75	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	301.85	10.48	18.87	15.02	2.10	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	246.30	10.88	9.37	14.51	1.21	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	318.69	5.26	8.69	11.50	1.35	0.61	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	671.43	21.83	44.10	50.22	1.75	2.77	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	319.42	12.17	22.51	20.69	1.83	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	369.52	7.23	12.06	14.47	0.60	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	210.36	12.44	8.14	9.50	0.90	1.13	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	300.74	16.18	11.38	12.28	1.50	1.50	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	305.69	7.44	10.74	16.18	1.06	1.53	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	186.76	15.15	8.32	9.61	0.64	0.85	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	387.03	14.42	21.03	19.83	1.80	4.81	0.60
Schwann Cells, donor1	11498-119F4	120.55	1.88	0.75	0.56	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	190.54	3.40	13.61	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	135.17	5.26	2.19	1.10	0.66	0.00	0.22
Sebocyte, donor1	11220-116B5	158.85	6.57	3.83	1.10	0.55	1.10	0.55
Sebocyte, donor2	11301-117B5	209.10	2.30	3.68	1.84	3.22	1.38	0.46
Sebocyte, donor3	11378-118B1	118.93	4.95	0.21	0.82	1.86	0.21	0.00
Sertoli Cells, donor1	11255-116F4	192.17	1.66	1.66	1.66	0.00	3.31	0.00
Sertoli Cells, donor2	11333-117F1	163.81	5.65	2.82	8.47	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	123.26	5.37	4.49	2.02	0.26	0.62	0.18
Skeletal Muscle Cells, donor2	11358-117H8	17.35	0.72	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	46.82	4.18	0.84	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	282.30	5.03	3.61	2.20	0.94	0.63	0.31
Skeletal Muscle Cells, donor5	11455-119A6	266.97	5.20	2.08	2.23	0.89	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	295.34	4.62	2.46	2.77	0.92	0.77	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	313.63	9.20	4.66	3.15	0.76	1.13	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	211.89	5.99	3.71	1.85	0.29	1.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	239.99	7.24	2.68	2.18	0.89	0.10	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	146.09	6.32	1.94	2.86	0.51	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	76.72	1.45	3.62	3.62	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	63.71	2.61	1.38	0.55	0.28	0.14	0.14
Skin - palm, donor1	10286-104F7	85.96	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	84.48	2.88	1.59	1.44	0.58	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	104.69	2.45	0.82	1.64	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	101.91	4.54	4.41	2.34	0.91	2.08	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	207.82	13.21	6.26	4.73	0.83	2.09	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	79.61	5.34	3.38	2.67	0.70	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	83.31	6.34	1.48	2.33	0.63	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	86.57	6.97	2.85	0.97	0.90	0.52	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	267.54	3.39	4.94	4.94	0.93	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	100.94	0.44	1.33	1.11	0.67	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	91.70	2.35	0.59	1.76	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	96.35	0.88	1.10	1.10	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	66.94	3.94	0.39	0.79	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	112.79	0.77	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	210.16	7.01	2.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	71.60	2.53	0.53	0.80	0.27	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	213.67	3.77	4.88	3.99	1.55	0.66	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	180.01	2.18	2.30	2.69	0.26	0.64	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	184.28	2.93	2.60	0.98	0.98	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	200.53	4.13	2.95	1.48	0.89	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	126.28	4.13	1.57	1.28	0.71	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	175.36	4.39	1.46	1.14	0.49	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	142.78	4.87	2.44	3.65	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	67.69	3.54	1.01	1.26	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	38.15	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	195.26	4.13	4.57	2.65	1.03	0.88	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	181.45	2.80	4.52	3.87	0.65	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	190.81	4.30	3.57	3.25	0.52	0.42	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	59.71	2.17	0.62	0.93	0.93	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	188.63	1.08	2.16	4.31	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	121.63	2.09	0.00	0.90	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	121.20	3.76	0.68	1.71	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	229.70	6.20	3.93	1.26	0.39	0.47	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	192.73	3.02	1.91	1.31	0.30	0.60	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	149.50	2.05	2.50	2.28	0.00	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	48.30	1.21	2.42	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	367.72	6.09	3.71	2.91	1.32	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	202.80	4.53	2.53	2.13	0.40	0.27	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	156.78	3.38	3.51	2.75	0.50	0.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	135.46	3.55	1.52	1.27	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	158.76	5.13	2.41	1.66	0.45	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	73.52	2.25	0.75	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	94.33	3.88	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	79.99	2.33	0.47	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	106.03	3.53	1.01	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	80.86	0.94	1.25	1.57	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	149.86	4.72	1.47	1.18	0.88	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	224.51	7.50	3.17	2.50	0.83	0.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	131.27	7.47	0.47	1.87	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	124.06	2.45	2.01	1.15	0.58	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	111.42	2.55	1.78	1.02	0.25	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	89.88	1.69	1.50	0.94	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	297.52	6.99	3.63	3.07	0.70	0.42	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	238.13	4.36	5.36	3.10	0.34	1.26	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	80.95	1.90	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	110.83	2.69	0.73	1.22	0.73	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	226.91	3.76	3.76	1.99	1.10	0.88	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	240.79	7.31	4.10	3.51	0.29	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	177.45	3.50	2.33	2.33	0.00	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	220.55	2.64	1.32	3.97	0.53	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	380.87	9.30	4.09	5.95	2.23	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	248.66	5.39	2.16	4.31	1.80	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	159.84	2.56	2.84	2.27	1.70	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	395.44	7.88	7.09	2.76	1.18	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	286.71	4.83	3.56	4.57	1.52	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	226.41	2.80	1.60	3.59	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	187.27	5.02	2.93	2.51	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	150.80	3.67	2.75	1.38	1.38	0.46	0.00
Synoviocyte, donor1	11291-117A4	200.81	3.37	2.86	3.87	1.01	0.00	0.34
Synoviocyte, donor2	11368-117I9	134.43	3.86	1.51	2.68	0.00	0.17	0.17
Synoviocyte, donor3	11440-118H9	124.44	3.13	1.79	1.34	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	168.30	2.50	1.79	1.79	0.36	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	107.03	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	57.42	2.55	0.46	2.08	0.46	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	188.31	7.38	4.01	2.22	1.43	1.22	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	64.94	3.48	1.16	0.00	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	63.57	2.86	1.15	0.57	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	133.85	11.93	0.74	0.49	0.37	0.00	0.25
Urethra, donor2	10319-105A4	73.74	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	176.13	8.50	2.39	1.33	1.86	1.06	0.80
Urothelial Cells, donor2	11600-120H7	132.59	8.81	1.60	3.20	0.80	0.40	0.80
Urothelial Cells, donor3	11681-122H7	71.97	6.65	0.46	0.46	0.69	0.23	0.46
Urothelial cells, donor0	11216-116B1	246.30	10.92	2.23	1.78	1.56	0.89	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	151.26	21.35	0.89	0.00	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	180.13	28.59	0.00	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	86.93	28.75	0.00	0.68	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	121.90	19.63	0.00	0.00	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	135.38	27.89	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	156.19	34.36	0.00	1.04	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	179.89	26.62	0.00	0.92	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	81.25	20.08	0.00	0.91	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	315.80	6.17	11.72	10.49	1.23	2.34	0.25
Wilms' tumor cell line:HFWT	10597-108E3	67.76	7.04	1.76	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	83.52	4.47	1.40	0.28	0.56	0.00	0.56
achilles tendon, donor2	10292-104G4	53.73	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	266.68	13.26	4.33	4.08	1.27	0.25	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	272.81	18.57	61.29	5.34	0.46	11.61	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	242.05	6.89	1.54	1.66	0.59	0.36	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	330.07	18.50	4.63	5.99	0.27	0.82	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	323.25	8.15	4.78	5.90	0.84	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	337.95	13.11	9.09	8.46	0.00	1.27	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	173.40	9.53	5.99	5.99	1.36	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	523.92	10.13	5.73	4.41	1.32	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	258.08	4.90	3.27	4.49	1.23	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	253.95	11.65	4.66	3.11	0.39	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	391.37	5.15	11.41	5.89	1.84	1.66	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	405.65	23.40	7.80	11.70	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	586.53	17.43	22.77	19.29	3.02	5.34	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	400.52	11.91	1.81	2.33	2.59	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	232.04	5.55	1.17	2.05	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	135.25	4.18	4.18	1.39	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	326.53	4.94	1.65	1.23	2.88	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	68.14	2.15	0.61	0.61	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	394.28	10.24	4.69	10.24	0.85	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	364.56	9.40	4.25	4.25	0.00	0.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	422.68	13.48	5.78	6.74	1.20	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	549.94	10.47	10.91	13.14	5.57	1.11	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	183.78	10.67	1.33	0.67	0.67	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	243.42	3.72	0.00	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	377.41	6.78	5.65	4.52	0.75	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	181.43	4.80	4.80	3.49	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	178.07	0.00	3.75	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	143.89	10.83	0.71	0.71	0.47	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	93.69	5.74	0.31	0.16	0.16	0.00	0.78
adipose, donor1	10184-103D4	834.46	13.49	13.49	10.56	2.93	4.69	0.00
adipose, donor2	10185-103D5	148.01	5.27	1.22	0.41	1.22	0.41	0.00
adipose, donor3	10186-103D6	161.47	9.80	3.00	2.72	0.54	1.36	0.54
adipose, donor4	10187-103D7	232.29	22.54	7.80	3.47	0.87	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	216.53	12.78	2.05	1.74	0.63	0.00	1.10
adrenal gland, adult, pool1	10081-102A9	54.57	7.28	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	264.14	3.87	2.13	2.40	0.80	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	470.21	8.93	7.50	8.22	0.36	0.71	1.07
amniotic membrane cells, donor1	12235-129G3	131.69	26.20	2.55	1.16	0.23	0.46	1.85
amniotic membrane cells, donor2	12236-129G4	231.60	24.34	0.34	1.01	0.68	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	129.62	27.69	0.29	0.29	0.88	0.29	0.88
amygdala - adult, donor10196	10167-103B5	111.46	0.00	1.19	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	92.87	2.23	0.81	1.82	0.61	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	113.94	5.49	1.94	3.23	0.97	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	549.17	17.44	5.22	6.11	0.76	1.02	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	458.01	11.69	5.29	6.18	2.87	0.66	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	254.87	8.68	6.35	5.01	0.67	0.33	0.00
aorta, adult, pool1	10052-101G7	93.16	1.57	0.20	0.59	0.00	0.00	0.00
appendix, adult	10189-103D9	103.24	6.60	1.16	0.00	0.39	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	279.62	11.35	1.03	2.75	0.34	0.00	0.69
artery, adult	10190-103E1	107.34	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	346.52	15.07	13.33	6.95	0.58	2.03	0.58
b cell line:RPMI1788	10427-106D4	200.45	4.46	2.08	2.23	0.59	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	160.92	3.33	1.66	1.94	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	156.39	8.04	1.09	0.89	0.69	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	189.47	16.57	3.18	2.85	0.84	0.17	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	166.65	11.74	1.68	1.12	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	123.74	3.80	0.43	0.22	0.11	0.00	0.00
blood, adult, pool1	10053-101G8	108.52	13.29	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	94.20	0.86	1.71	1.71	0.86	0.00	0.00
bone marrow, adult	10192-103E3	168.03	2.70	6.07	3.37	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	72.78	1.03	2.05	3.08	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	94.21	0.67	0.78	1.45	0.22	0.00	0.00
brain, fetal, pool1	10085-102B4	138.91	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	198.88	30.06	1.32	2.64	1.32	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	170.01	4.12	1.00	0.87	0.37	0.37	0.25
breast, adult, donor1	10080-102A8	57.45	5.68	0.00	0.00	0.00	0.00	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	236.04	10.42	4.95	2.03	1.78	0.76	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	297.47	12.68	24.12	8.35	3.71	4.64	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	653.59	33.38	8.75	8.75	2.76	0.23	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	144.53	9.20	0.97	0.73	0.48	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	339.46	15.99	6.58	5.64	0.94	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	135.08	20.89	0.22	0.22	0.44	0.11	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	481.68	5.70	10.77	6.65	0.95	2.22	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	254.20	10.91	3.73	3.46	0.27	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	135.86	1.15	0.00	1.15	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	105.42	1.51	1.00	2.18	0.33	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	191.03	0.76	2.29	1.53	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	125.98	5.49	1.46	1.83	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	119.44	0.00	0.00	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	117.43	2.14	0.21	0.43	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	85.20	0.69	0.69	1.03	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	192.63	5.81	0.00	2.49	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	86.48	1.01	1.01	0.25	0.50	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	57.01	2.19	0.73	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	354.28	6.76	2.30	1.29	0.43	0.29	0.14
cervical cancer cell line:ME-180	10553-107I4	313.87	10.44	9.61	4.47	1.16	1.49	1.16
cervix, adult, pool1	10013-101C4	122.52	6.30	1.57	1.36	0.42	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	217.09	4.46	2.37	1.81	0.42	0.14	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	67.93	0.00	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	217.36	10.19	2.11	0.99	0.62	0.12	0.62
choriocarcinoma cell line:SCH	10785-110H2	210.69	4.44	6.65	3.82	0.49	1.11	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	237.89	5.69	3.79	2.13	1.66	0.47	0.95
chorionic membrane cells, donor1	12238-129G6	138.19	12.54	3.42	1.14	0.28	0.57	1.42
chorionic membrane cells, donor2	12239-129G7	182.36	5.47	3.18	1.89	0.50	0.80	0.30
chorionic membrane cells, donor3	12240-129G8	180.23	4.40	5.49	2.75	1.10	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	288.80	8.08	6.06	3.03	4.04	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	343.09	4.23	4.03	3.46	1.73	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	185.63	4.22	3.17	2.75	0.84	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	280.17	7.19	1.03	1.54	2.57	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	264.86	10.16	0.48	2.42	2.18	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	247.18	12.62	0.41	1.02	1.83	0.20	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	426.96	15.31	1.47	2.06	0.88	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	270.27	8.08	5.47	3.39	0.26	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	195.67	6.86	0.91	2.51	0.91	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	348.05	17.00	2.43	2.08	2.26	0.35	0.69
colon carcinoma cell line:CACO-2	10513-107D9	377.80	48.69	18.30	8.05	1.65	1.83	2.75
colon carcinoma cell line:COLO-320	10420-106C6	519.19	7.98	7.60	10.26	1.52	0.38	1.14
colon, adult, donor1	10082-102B1	95.20	10.71	1.19	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	139.12	15.51	0.47	0.82	0.24	0.24	0.47
colon, fetal, donor1	10070-101I7	108.15	7.42	2.47	0.00	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	600.88	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	364.59	6.37	21.67	29.32	3.40	2.12	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	434.23	10.41	33.81	38.34	1.21	1.81	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	490.72	8.74	33.56	34.69	1.55	2.96	0.85
corpus callosum, adult, pool1	10042-101F6	117.09	0.77	0.88	1.11	0.44	0.11	0.00
cruciate ligament, donor2	10295-104G7	81.86	5.67	0.00	1.62	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	80.26	4.01	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	113.51	0.72	0.96	1.44	1.20	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	286.33	9.64	3.21	3.21	0.00	0.69	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	268.24	15.39	9.74	4.62	1.54	1.54	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	303.31	12.76	5.06	8.67	3.37	0.96	1.20
ductus deferens, adult	10196-103E7	99.17	3.49	0.00	0.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	97.94	17.28	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	153.75	14.71	0.74	1.47	0.74	0.00	1.47
dura mater, adult, donor1	10041-101F5	108.35	2.81	0.41	1.16	0.08	0.08	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	176.33	12.44	9.10	13.55	2.00	1.55	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	284.44	11.18	2.44	3.30	1.86	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	329.89	9.87	14.18	11.72	4.32	4.93	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	414.71	6.96	9.99	9.99	1.51	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	388.10	9.26	7.72	10.50	1.23	1.85	0.93
embryonic pancreas cell line:2C6	10603-108E9	302.10	3.94	11.82	10.51	0.00	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	281.23	9.39	15.08	12.74	2.01	2.01	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	274.93	13.41	8.52	4.53	0.00	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	233.50	9.49	1.29	2.41	1.13	0.80	0.48
epidermoid carcinoma cell line:A431	10426-106D3	184.63	7.67	3.45	3.22	1.00	1.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	251.65	21.67	2.97	3.30	1.76	0.33	2.09
epididymis, adult	10197-103E8	117.63	2.72	1.47	2.09	0.21	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	189.12	6.39	0.71	1.60	0.71	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	141.17	3.93	4.33	2.75	0.00	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	316.75	8.39	2.88	4.19	0.92	0.13	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	257.17	4.33	5.22	4.04	0.59	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	327.46	8.63	4.15	4.26	1.12	0.00	0.22
esophagus, adult, pool1	10015-101C6	138.88	17.63	0.85	0.64	0.11	0.21	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	286.92	5.26	3.26	3.01	0.38	0.75	0.38
eye - muscle inferior rectus, donor1	10272-104E2	43.46	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	65.23	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	28.28	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	65.35	3.44	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	94.73	1.46	1.46	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	130.17	4.83	0.51	0.25	1.27	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	286.32	5.39	6.03	5.26	1.54	1.80	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	316.72	7.36	3.09	0.95	1.90	0.47	0.95
frontal lobe, adult, pool1	10040-101F4	117.75	0.47	0.94	1.31	0.09	0.09	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	623.62	32.43	15.01	10.51	3.00	0.90	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	336.76	9.97	1.19	1.55	0.91	0.18	0.55
gall bladder, adult	10198-103E9	95.85	1.93	0.24	0.48	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	150.32	9.13	0.54	0.00	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	168.44	6.35	0.75	1.49	0.00	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	569.44	11.19	13.52	10.98	1.90	1.06	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	92.84	5.80	0.77	0.19	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	333.65	11.48	9.67	7.38	0.49	1.80	0.82
gastric cancer cell line:GSS	10560-108A2	288.30	29.29	0.00	2.75	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	238.28	10.97	2.28	2.28	2.51	0.00	0.69
giant cell carcinoma cell line:LU65	10487-107B1	652.41	34.54	4.25	4.36	4.47	0.46	3.21
giant cell carcinoma cell line:Lu99B	10433-106E1	373.83	5.74	2.10	2.10	1.96	0.56	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	190.31	5.49	3.24	2.74	2.00	1.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	194.11	7.49	3.69	3.80	0.74	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	192.82	7.30	2.53	2.39	0.56	0.42	0.42
glioblastoma cell line:T98G	10485-107A8	156.07	6.62	0.44	0.66	0.22	0.00	0.33
glioma cell line:GI-1	10413-106B8	268.86	8.79	7.91	9.96	0.29	2.34	0.29
globus pallidus - adult, donor10196	10175-103C4	135.58	1.46	0.00	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	131.81	2.20	0.00	0.24	0.98	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	121.86	1.37	2.74	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	121.51	8.53	1.07	1.07	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	2.45	0.00	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	21.86	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	433.81	20.91	5.23	15.68	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	103.68	1.60	3.84	1.60	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	526.15	19.28	22.96	12.40	3.67	8.72	0.46
hIPS +CCl2, biol_rep2	14384-156C1	449.03	16.46	14.18	15.09	0.00	8.69	2.29
hIPS +CCl2, biol_rep3	14385-156C2	475.34	19.97	18.03	13.53	3.22	6.44	0.64
hIPS, biol_rep1	14380-156B6	533.23	12.94	24.43	23.00	4.31	7.19	0.00
hIPS, biol_rep2	14381-156B7	371.05	14.40	20.58	10.97	3.43	9.60	3.43
hIPS, biol_rep3	14382-156B8	228.42	1.10	6.62	1.10	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	277.57	4.60	5.75	6.90	1.72	0.00	0.00
heart - mitral valve, adult	10205-103F7	105.83	4.19	0.00	0.60	0.00	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	100.41	1.05	0.26	0.78	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	105.75	8.33	0.00	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	119.17	7.14	1.84	0.82	0.20	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	77.93	2.13	0.00	0.43	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	62.78	1.15	0.00	0.46	0.92	0.00	0.23
heart, fetal, pool1	10046-101G1	170.35	3.49	2.26	1.33	0.31	0.00	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	117.86	1.85	0.93	0.93	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	84.43	13.08	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	221.21	23.54	7.18	4.86	0.99	0.77	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	219.57	20.63	5.95	6.07	1.46	0.97	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	235.45	23.55	7.58	4.95	0.40	1.01	2.22
hepatoma cell line:Li-7	10484-107A7	158.04	5.45	2.34	2.00	0.00	0.56	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	332.46	10.75	14.67	7.44	1.41	1.51	0.20
hippocampus - adult, donor10196	10169-103B7	110.72	0.95	0.95	3.79	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	103.07	3.06	0.61	0.82	0.00	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	167.31	0.00	1.49	2.49	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	69.09	2.11	1.06	0.70	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	660.39	47.00	32.96	17.09	1.83	6.10	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	260.56	26.70	10.60	3.34	1.57	1.96	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	290.96	31.48	9.65	5.84	1.02	1.27	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	232.31	10.15	2.26	0.56	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	276.29	5.94	5.42	4.39	0.26	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	321.53	9.11	3.80	3.42	0.76	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	194.44	9.63	3.21	3.80	1.17	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	172.56	12.71	1.51	2.37	1.08	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	188.10	10.01	5.00	4.59	1.25	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	267.81	10.42	5.45	5.68	0.95	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	232.88	13.02	5.63	5.14	0.64	0.64	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	286.83	12.12	3.37	4.04	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	254.60	28.79	10.33	6.42	1.88	1.10	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	325.73	26.04	13.76	11.30	1.97	3.44	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	741.84	70.69	37.53	25.31	2.62	11.35	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	260.21	5.92	3.63	2.29	0.38	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	240.28	5.23	4.36	3.05	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	398.81	6.50	7.00	8.00	1.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	189.52	7.72	1.32	1.13	1.51	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	226.90	8.64	2.27	1.82	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	209.24	9.40	2.19	1.25	0.94	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	203.96	7.68	4.57	3.59	0.33	0.49	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	214.25	5.23	2.90	2.90	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	195.20	4.48	4.18	3.89	1.79	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	280.81	25.49	7.76	4.99	1.66	1.48	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	235.64	18.83	9.98	4.28	0.86	0.86	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	455.68	33.89	20.82	7.76	0.82	2.04	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	253.50	7.75	4.22	5.63	0.00	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	205.56	7.92	3.80	4.12	0.95	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	247.85	8.47	3.03	3.63	0.61	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	156.69	6.21	2.07	1.03	3.10	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	175.34	6.64	1.99	2.66	0.66	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	199.84	9.75	3.85	2.31	2.05	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	200.68	4.86	4.86	5.37	1.02	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	232.47	5.30	3.79	3.79	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	237.26	8.40	5.04	5.71	0.00	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	247.30	22.46	10.87	5.07	0.97	0.48	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	372.13	24.96	20.95	11.59	0.89	1.34	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	267.32	17.56	9.76	4.88	2.93	1.46	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	215.15	6.11	3.36	1.53	0.92	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2866.11	55.31	32.53	48.80	9.76	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	408.38	8.60	5.30	3.31	1.99	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	190.46	3.83	0.55	2.19	0.00	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	184.92	10.49	2.17	1.09	1.45	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	182.21	10.32	1.78	3.20	2.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	231.52	7.16	4.77	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	235.23	9.21	4.47	2.71	0.95	0.27	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	188.85	11.31	4.31	5.39	1.62	0.00	0.27
immature langerhans cells, donor1	11904-125F5	131.49	4.60	3.63	2.18	0.24	0.97	0.00
immature langerhans cells, donor2	11905-125F6	91.89	36.44	2.38	2.38	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	94.44	0.47	1.32	1.14	0.28	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	249.71	10.73	12.36	8.13	1.30	0.33	0.33
kidney, adult, pool1	10017-101C8	158.80	10.71	0.30	1.10	0.30	0.10	0.00
kidney, fetal, pool1	10045-101F9	117.63	8.91	0.57	0.71	0.21	0.00	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	358.46	10.79	10.37	7.67	1.99	2.98	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	167.83	4.98	12.30	6.77	0.97	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	281.67	14.86	7.34	5.69	2.57	0.55	1.28
left atrium, adult, donor1	10079-102A7	90.45	3.81	0.00	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	100.12	2.53	0.51	0.51	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	259.66	6.84	3.83	3.56	0.82	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	168.49	3.23	1.80	3.59	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	158.15	4.35	2.17	5.98	1.63	1.09	0.54
leiomyoma cell line:15425	10571-108B4	173.13	4.61	2.19	3.64	0.97	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	171.43	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	116.06	4.18	0.00	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	311.08	2.60	19.01	13.46	0.83	3.19	0.00
liposarcoma cell line:KMLS-1	10782-110G8	215.88	11.87	4.53	3.91	0.78	0.94	1.09
liposarcoma cell line:SW 872	10726-110A6	125.25	5.36	2.19	1.22	0.24	0.24	0.24
liver, adult, pool1	10018-101C9	132.40	5.67	0.32	0.16	0.16	0.16	0.32
liver, fetal, pool1	10086-102B5	68.67	3.76	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	79.62	1.46	0.15	1.17	0.58	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	106.12	3.14	0.18	0.18	0.55	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	89.44	0.56	0.85	0.85	0.56	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	188.02	8.83	0.84	1.26	0.84	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	141.30	13.29	6.09	1.94	0.42	0.28	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	151.67	7.58	0.00	0.00	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	372.78	18.45	13.18	10.68	3.69	3.16	1.19
lung, adult, pool1	10019-101D1	98.40	8.15	0.47	0.47	0.24	0.00	0.24
lung, fetal, donor1	10068-101I5	314.80	14.56	1.14	0.29	0.29	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	101.72	5.50	0.46	1.83	1.83	0.00	0.46
lymph node, adult, donor1	10077-102A5	56.33	7.57	0.95	0.00	0.00	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	174.25	12.93	1.75	2.85	0.66	0.44	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	292.34	21.28	3.47	3.92	0.00	0.45	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	369.53	10.19	7.65	11.89	0.85	2.55	0.00
mature adipocyte, donor1	12231-129F8	84.36	0.89	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	118.08	3.11	0.42	0.42	0.42	0.00	0.42
mature adipocyte, donor3	12233-129G1	96.96	2.37	0.47	0.95	0.24	0.00	0.47
mature adipocyte, donor4	12234-129G2	140.82	3.95	0.26	0.79	0.53	0.26	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	210.14	13.10	0.24	1.91	0.48	0.24	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	99.27	2.26	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	87.17	2.39	0.55	0.00	0.74	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	213.17	1.27	0.00	4.13	1.27	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	303.23	5.54	6.40	7.68	2.56	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	113.57	0.84	0.84	1.52	0.17	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	96.99	1.06	0.21	0.64	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	156.03	3.85	0.00	3.85	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	105.89	4.67	2.15	1.79	0.72	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	125.25	1.95	0.00	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	94.12	1.86	0.46	0.62	0.62	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	93.87	1.22	0.24	0.41	0.41	0.08	0.08
medulla oblongata, newborn, donor10223	10361-105F1	115.26	5.21	0.00	0.35	0.69	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	415.81	4.87	13.73	12.18	2.21	1.99	0.00
medulloblastoma cell line:ONS-76	10759-110E3	101.12	5.75	0.73	0.24	0.00	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	188.31	5.61	6.04	5.03	0.72	0.43	0.14
melanoma cell line:G-361	10465-106H6	394.98	2.17	5.43	4.07	1.09	1.63	0.81
meningioma cell line:HKBMM	10691-109F7	165.71	3.08	1.09	1.45	0.36	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	357.75	5.29	5.29	6.17	0.88	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	307.44	8.55	1.30	1.81	0.52	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	266.67	4.76	5.06	3.68	0.46	0.77	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	185.96	5.09	3.45	4.91	0.36	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	225.27	2.90	4.14	2.90	1.24	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	170.96	2.67	1.55	1.55	0.28	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	185.44	4.04	4.04	2.50	0.00	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	165.88	5.55	0.69	2.08	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	163.57	3.09	4.46	2.06	0.17	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	154.01	2.19	1.84	1.96	0.23	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	243.12	2.92	2.92	2.92	0.13	0.80	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	207.02	2.84	2.57	2.43	0.27	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	180.67	3.13	1.71	1.71	0.28	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	95.18	3.29	1.98	0.99	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	206.87	3.74	5.12	1.94	0.42	1.11	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	205.26	0.70	3.84	3.14	0.35	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	220.09	2.04	2.65	1.43	0.61	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	99.21	3.95	2.16	0.72	0.36	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	189.11	2.17	1.03	0.93	0.31	0.21	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	100.32	3.19	0.91	1.82	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	292.43	5.03	5.03	5.45	1.26	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	189.64	1.94	2.09	2.99	0.45	0.00	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	163.42	5.69	2.36	1.23	0.35	0.44	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	143.95	5.15	1.47	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	105.88	2.58	2.29	0.86	0.57	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	270.71	4.63	5.05	7.16	0.42	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	157.55	5.94	4.11	2.28	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	156.54	5.63	2.56	4.86	0.51	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	154.17	3.66	4.45	3.93	0.26	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	141.72	5.85	3.39	2.46	0.62	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	175.10	6.83	3.53	4.00	0.24	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	170.92	4.74	3.38	3.38	0.68	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	155.62	5.11	4.72	0.39	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	145.97	3.24	5.10	6.02	1.39	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	196.99	6.63	5.48	3.17	0.29	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	153.05	4.91	1.78	2.23	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	154.31	4.33	3.36	1.68	0.72	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	152.53	7.33	2.20	3.67	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	145.00	4.36	3.02	3.02	1.01	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	171.53	5.32	2.87	2.87	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	158.08	4.30	4.73	3.44	0.86	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	133.99	2.73	2.73	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	139.45	10.33	5.16	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	192.92	5.20	6.50	4.22	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	125.13	4.36	5.82	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	149.80	3.73	1.60	3.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	137.39	5.72	0.82	5.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	168.70	4.66	2.72	1.55	0.78	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	130.12	2.10	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	129.15	6.95	2.98	5.96	0.00	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	181.15	0.00	0.00	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	142.31	3.56	3.56	3.56	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	148.65	2.44	3.66	3.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	158.35	3.17	1.27	4.43	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	130.03	6.21	2.41	2.07	0.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	116.06	0.00	6.45	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	131.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	192.86	0.00	10.33	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	127.95	2.04	1.63	6.11	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	121.55	3.18	3.97	2.38	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	124.98	4.13	0.00	2.95	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	126.55	1.25	2.49	4.36	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	89.56	0.00	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	134.82	3.55	4.73	3.55	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	151.51	0.00	0.00	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	138.37	3.44	1.38	2.75	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	123.21	3.96	0.00	0.99	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	107.66	1.12	4.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	128.48	2.54	0.00	1.91	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	130.57	1.61	0.00	0.81	0.81	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	104.67	4.36	0.00	2.18	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	87.43	3.80	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	109.85	3.64	0.61	2.43	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	140.09	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	102.14	4.12	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	166.68	1.98	1.19	1.98	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	130.77	0.97	1.95	1.62	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	110.01	2.04	2.04	1.02	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	93.62	0.77	2.32	1.55	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	302.15	4.25	2.13	2.36	2.36	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	237.93	5.79	3.01	3.94	0.46	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	192.31	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	562.87	7.91	9.56	7.50	0.82	1.64	0.21
mesothelioma cell line:Mero-25	10850-111F4	79.66	1.59	1.59	1.59	0.91	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	211.47	8.31	1.22	2.44	0.98	0.24	0.49
mesothelioma cell line:Mero-48a	10852-111F6	239.81	6.64	3.32	4.21	0.44	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	160.31	3.15	15.77	9.20	2.10	2.63	0.26
mesothelioma cell line:Mero-83	10854-111F8	232.35	2.38	5.11	3.40	1.19	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	125.63	6.82	1.52	0.76	1.01	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	149.69	5.59	2.90	1.66	0.21	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	325.50	8.78	4.31	2.32	2.15	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	169.23	2.71	1.99	1.63	0.72	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	216.60	4.95	1.88	1.71	0.51	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	249.38	16.54	3.82	4.33	1.78	0.25	0.51
mesothelioma cell line:No36	10857-111G2	221.49	7.83	1.30	0.98	1.30	0.00	1.30
mesothelioma cell line:ONE58	10858-111G3	220.01	2.98	5.42	6.23	1.63	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	168.51	9.21	0.77	0.58	0.19	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	97.57	5.01	0.12	0.37	0.24	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	182.17	4.85	1.26	0.90	0.18	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	213.52	4.57	1.96	3.26	0.33	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	175.91	12.29	13.78	3.81	1.70	3.39	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	136.37	8.98	3.69	1.15	1.38	1.38	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	184.20	4.19	5.90	5.90	0.38	1.14	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	492.66	14.41	4.25	4.25	1.11	0.55	0.55
myeloma cell line:PCM6	10474-106I6	197.07	8.30	3.16	2.57	0.00	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	108.56	3.55	7.61	4.57	0.00	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	141.61	2.55	0.98	0.59	0.20	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	216.72	15.27	0.56	0.45	1.00	0.45	0.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	271.36	15.88	1.99	1.76	1.47	0.51	0.51
nasal epithelial cells, donor2	12227-129F4	188.78	4.97	2.76	2.76	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	268.71	7.13	12.88	15.64	0.46	1.38	0.46
neuroblastoma cell line:NB-1	10539-107G8	361.82	8.79	4.86	10.29	1.12	0.37	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	235.14	2.11	15.61	8.65	0.63	1.48	0.00
neuroblastoma cell line:NH-12	10555-107I6	400.10	5.78	10.44	8.57	1.49	1.49	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	174.84	4.74	3.08	4.98	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	261.64	4.43	2.53	3.64	0.00	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	170.06	3.62	2.62	1.41	0.20	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	112.53	1.27	1.91	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	126.16	3.19	2.93	2.13	0.00	0.53	0.00
neutrophil PMN, donor1	12133-128D9	44.62	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	225.77	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	236.77	56.82	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	329.45	8.46	3.55	0.51	0.34	0.51	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	828.53	66.44	6.40	4.00	2.40	0.00	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	180.82	6.73	7.05	2.24	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	131.12	4.73	2.89	3.68	0.00	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	93.83	0.84	0.84	0.75	0.56	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	123.62	0.00	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	94.20	1.88	0.00	0.81	0.27	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	80.43	3.64	1.09	1.09	0.36	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	102.34	0.52	0.52	1.84	0.52	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	239.44	2.15	2.57	3.43	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	55.35	0.55	0.39	0.08	0.16	0.08	0.16
olfactory region, adult	10195-103E6	82.15	0.19	0.96	0.57	0.38	0.00	0.00
optic nerve, donor1	10277-104E7	104.05	4.00	0.00	2.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	267.57	11.16	5.81	6.83	0.91	0.91	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	441.01	3.85	10.44	4.12	2.89	1.37	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	163.06	7.11	6.60	5.59	0.34	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	198.21	9.93	9.70	4.85	0.69	1.85	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	98.77	2.35	2.06	1.18	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	271.89	1.87	6.54	4.67	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	304.09	9.97	4.24	3.61	0.64	0.42	0.85
ovary, adult, pool1	10020-101D2	102.03	4.54	0.70	1.22	0.26	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	192.67	6.60	4.22	2.93	1.28	0.37	0.55
pancreas, adult, donor1	10049-101G4	101.59	7.53	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	110.70	5.59	0.56	0.56	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	260.64	2.04	2.56	4.43	0.68	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	236.12	13.74	2.65	2.15	1.32	0.17	1.49
paracentral gyrus, adult, pool1	10035-101E8	85.21	0.64	0.73	1.01	0.37	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	168.82	2.20	0.73	0.73	1.47	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	101.57	0.94	0.94	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	80.10	1.71	0.00	0.29	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	76.66	1.06	0.26	1.15	0.26	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	252.16	1.94	0.97	2.91	2.91	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	103.19	5.61	1.87	2.99	1.12	0.37	0.00
parotid gland, adult	10199-103F1	80.17	4.32	0.00	0.00	0.62	0.00	0.00
penis, adult	10200-103F2	102.05	2.69	0.00	2.69	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	271.65	2.97	0.37	0.56	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	133.46	9.76	2.04	1.17	0.44	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	85.14	1.29	0.00	0.65	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	141.54	4.74	0.00	0.59	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	195.02	1.88	0.63	1.25	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	217.54	3.04	3.04	2.02	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	218.37	11.99	0.52	0.00	0.00	0.00	1.56
pituitary gland, adult, donor10258	10378-105G9	336.24	5.11	0.85	5.11	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	111.59	12.47	1.29	0.75	0.43	0.00	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	234.79	7.15	3.18	3.97	1.06	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	155.79	4.36	0.31	0.78	1.25	0.16	0.16
pons, adult, pool1	10033-101E6	81.94	0.52	0.52	0.60	0.09	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	81.25	0.61	0.17	0.44	0.35	0.26	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	380.05	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	445.96	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	305.02	6.55	5.54	2.04	1.02	1.02	0.87
prostate cancer cell line:PC-3	10439-106E7	294.21	10.89	2.72	2.00	0.73	0.18	0.36
prostate, adult, pool1	10022-101D4	111.55	7.07	0.27	0.18	0.27	0.00	0.09
putamen, adult, donor10196	10176-103C5	95.84	0.71	0.94	1.18	0.00	0.24	0.00
putamen, adult, donor10252	10152-102I8	154.90	7.84	1.96	0.00	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	330.03	9.84	8.74	8.74	1.09	6.56	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	135.79	0.48	1.93	1.21	0.72	0.72	0.00
putamen, newborn, donor10223	10365-105F5	252.64	10.50	1.50	5.25	2.25	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	136.74	10.76	2.33	1.16	1.16	0.00	0.58
rectum, fetal, donor1	10067-101I4	147.45	5.56	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	160.91	16.96	0.42	0.42	1.06	0.00	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	195.92	11.60	0.41	0.41	0.00	0.00	0.83
retina, adult, pool1	10030-101E3	93.24	2.78	0.20	0.30	0.00	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	450.24	7.53	8.05	3.12	1.30	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	162.54	2.58	9.47	4.30	0.61	0.98	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	128.51	14.06	1.97	0.84	0.56	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	90.18	5.30	0.76	0.00	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	156.68	4.37	6.15	3.24	0.65	0.32	0.00
salivary acinar cells, donor2	11772-123I8	140.72	5.65	4.96	3.99	0.41	0.28	0.00
salivary acinar cells, donor3	11773-123I9	58.26	5.30	0.00	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	155.57	6.29	0.57	0.00	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	71.92	5.73	2.02	1.01	0.25	0.17	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	71.35	5.88	2.47	0.71	0.24	0.24	0.12
seminal vesicle, adult	10201-103F3	100.52	1.59	0.00	0.00	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	240.25	24.54	5.83	6.07	2.67	1.21	2.67
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	131.60	9.56	0.50	1.51	0.25	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	202.71	13.05	0.00	1.00	2.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	160.65	10.21	1.48	1.07	0.67	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	293.45	7.74	6.52	3.65	1.11	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	212.38	10.84	4.39	3.35	0.77	0.13	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	84.41	0.00	0.00	0.00	0.00	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	107.46	3.12	0.00	0.12	0.12	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	94.47	3.02	0.00	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	94.99	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	154.02	7.57	1.26	0.63	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	238.80	11.34	1.33	3.67	3.67	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	315.84	10.09	2.52	1.89	0.95	0.00	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	466.83	5.59	4.63	5.20	2.31	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	507.01	17.47	8.08	6.76	2.80	0.33	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	341.00	8.20	0.16	1.13	2.09	0.00	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	319.90	12.42	8.50	9.59	0.87	1.96	0.44
small intestine, adult, pool1	10024-101D6	177.49	33.56	1.43	1.07	0.96	0.00	1.67
small intestine, fetal, donor1	10064-101I1	116.95	14.99	0.00	0.98	0.25	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	259.01	8.72	0.51	4.62	1.54	0.51	1.54
smooth muscle, adult, pool1	10048-101G3	106.23	2.33	0.26	1.29	0.52	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	171.27	10.18	1.88	2.95	1.07	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	114.24	2.29	0.92	0.92	0.69	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	108.42	3.55	0.79	0.39	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	388.10	2.77	2.77	2.77	2.08	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	175.63	1.83	2.44	0.61	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	208.02	5.51	2.76	1.84	0.46	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	102.46	3.58	2.39	1.94	0.15	0.30	0.30
spleen, adult, pool1	10025-101D7	104.41	8.15	0.33	0.44	0.00	0.00	0.55
spleen, fetal, pool1	10044-101F8	91.14	6.59	0.40	0.32	0.00	0.00	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	205.78	5.28	3.00	3.21	0.41	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	239.24	11.96	11.20	4.94	1.52	1.71	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	223.30	12.93	3.49	3.49	0.35	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	236.90	8.99	1.17	1.95	1.56	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	581.14	107.04	2.48	2.25	4.95	0.79	5.40
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	604.90	23.72	8.90	6.35	2.12	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	305.46	1.27	13.96	8.46	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	79.03	6.41	0.00	2.14	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	87.73	6.84	0.00	0.00	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	112.37	2.49	0.42	0.42	0.42	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	165.52	2.07	1.55	2.07	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	125.77	4.24	1.41	1.41	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	273.28	6.42	4.59	7.57	0.00	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	66.71	0.17	0.42	0.85	0.17	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	250.72	1.42	4.99	2.14	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	228.56	1.76	2.20	4.40	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	155.70	4.19	1.40	2.79	0.00	0.35	0.00
tenocyte, donor2	11765-123I1	117.89	5.34	0.76	1.53	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	151.23	2.97	2.22	4.45	0.37	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	406.55	12.24	7.48	5.95	1.02	0.85	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	324.94	11.25	11.41	3.85	0.92	1.85	0.46
teratocarcinoma cell line:PA-1	10807-111A6	180.55	10.85	1.55	1.24	0.31	0.62	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	257.07	6.73	3.30	3.17	1.52	0.63	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	337.33	9.08	4.92	3.78	0.38	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	451.63	26.50	2.51	4.04	1.96	0.65	2.84
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	583.33	14.01	2.93	7.49	3.91	0.33	0.98
testis, adult, pool1	10026-101D8	140.12	7.41	1.07	1.93	2.68	0.64	1.61
testis, adult, pool2	10096-102C6	170.96	7.22	3.16	1.35	6.32	0.90	3.16
thalamus - adult, donor10196	10168-103B6	162.29	2.21	2.21	2.21	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	123.15	3.75	0.31	0.78	0.63	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	274.05	0.00	1.54	1.54	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.87	0.49	0.16	0.49	0.16	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	110.46	5.18	2.30	2.88	2.30	1.15	0.00
throat, adult	10209-103G2	89.88	7.99	0.50	1.00	0.50	0.25	0.25
throat, fetal, donor1	10061-101H7	158.14	5.48	0.91	0.91	0.00	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	381.56	4.97	12.32	9.14	0.79	0.99	0.20
thymus, adult, pool1	10027-101D9	156.88	10.74	0.70	0.70	0.20	0.10	0.70
thymus, fetal, pool1	10043-101F7	169.99	9.25	0.52	0.83	0.31	0.00	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	233.21	12.63	2.79	1.86	0.66	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	259.13	8.24	1.68	0.98	0.56	0.00	0.28
thyroid, adult, pool1	10028-101E1	163.39	15.02	0.47	0.56	0.37	0.00	0.47
thyroid, fetal, donor1	10060-101H6	139.48	3.95	0.79	0.26	1.05	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	144.43	6.51	1.86	1.86	0.00	0.00	0.23
tongue, fetal, donor1	10059-101H5	195.86	5.12	1.18	1.18	1.58	0.00	0.39
tonsil, adult, pool1	10047-101G2	133.03	11.82	0.90	0.60	0.20	0.20	0.60
trachea, adult, pool1	10029-101E2	123.03	9.24	1.23	0.90	0.25	0.16	0.65
trachea, fetal, donor1	10058-101H4	125.80	4.23	1.15	0.77	0.00	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	147.02	5.31	1.06	2.83	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	219.76	17.02	6.28	2.84	0.10	0.61	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	273.89	8.77	6.74	2.51	0.78	0.78	0.31
tridermal teratoma cell line:HGRT	10694-109G1	127.47	5.71	3.81	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	195.80	8.72	4.57	5.42	0.42	0.42	0.51
umbilical cord, fetal, donor1	10057-101H3	104.33	0.00	4.17	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	143.67	1.54	1.02	1.02	0.00	0.00	0.17
uterus, fetal, donor1	10055-101H1	162.79	5.63	1.02	2.56	1.54	1.02	2.05
vagina, adult	10204-103F6	69.14	10.34	0.00	0.00	0.00	0.00	1.29
vein, adult	10191-103E2	88.34	6.14	0.00	0.44	0.00	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	150.34	4.27	2.67	1.34	0.80	0.80	0.27